Terminated PHASE2 INTERVENTIONAL 2-arm NCT00321308

Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer

A Randomized Phase II Trial Of Pemetrexed With Or Without PF-3512676 For The Treatment Of Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer After Failure Of One Prior Chemotherapy Regimen For Advanced Disease

Sponsor: Pfizer

Conditions Carcinoma, Non-Small Cell Lung

Interventions pemetrexed pemetrexed + PF-3512676

Updated 8 times since 2017 Last updated: Sep 24, 2009 Started: Sep 30, 2006 Primary completion: Jan 31, 2008 Completion: Jan 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

See Termination Reason in Detailed Description.

Other terminated trials from Pfizer

See all terminations from Pfizer

Other Carcinoma, Non-Small Cell Lung trials with similar outcome

Browse all Carcinoma, Non-Small Cell Lung trials

Listed as NCT00321308, this PHASE2 trial focuses on Carcinoma, Non-Small Cell Lung and remains terminated or withdrawn. Sponsored by Pfizer, it has been updated 8 times since 2006, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE2
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Apr 2022 — Jul 2024 [monthly]

Terminated PHASE2
Jan 2021 — Apr 2022 [monthly]

Terminated PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pfizer

Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bentonville, United States , Fayetteville, United States , Großhansdorf, Germany , Hudson, United States , Litchfield Park, United States , Mahwah, United States , Mannheim, Germany , Midland Park, United States , New Port Richey, United States , Oneida, United States and 8 more locations